1. Inicio
  2. Publicaciones
  3. Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients

Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Carrasco, I
  • Sainz, T
  • Frick, MA
  • de Ory, SJ
  • Fortuny, C
  • Burgos, J
  • Gavilan, C
  • Falcon, MD
  • Couceiro, JA
  • Bernardino, JI
  • Bisbal, O
  • Guerrero, C
  • Aldamiz-Echevarria, MT
  • Berenguer, J
  • Navarro, ML

Grupos

Abstract

Direct-acting antivirals (DAAs) for HCV treatment have improved tolerance and efficacy among adults, but experience in vertical transmission is scarce. In our vertically HIV/HCV co-infected youth cohort of 58 patients, DAA achieved excellent rates of cure among naive and pretreated individuals. Treating vertically infected seems important as 29.6% displayed advanced fibrosis at treatment initiation.

Datos de la publicación

ISSN/ISSNe:
1352-0504, 1365-2893

JOURNAL OF VIRAL HEPATITIS  WILEY

Tipo:
Article
Páginas:
955-958
PubMed:
32347645
Factor de Impacto:
1,329 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 9

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • children and adolescents; direct-acting antivirals; HCV treatment; vertical transmission; VIH; VHC co-infection

Cita

Compartir